Methyl 3,4,5-trimethoxyanthranilate - CAS 5035-82-5
Catalog: |
BB027026 |
Product Name: |
Methyl 3,4,5-trimethoxyanthranilate |
CAS: |
5035-82-5 |
Synonyms: |
methyl 2-amino-3,4,5-trimethoxybenzoate |
IUPAC Name: | methyl 2-amino-3,4,5-trimethoxybenzoate |
Description: | Methyl 2-Amino-3,4,5-trimethoxybenzoate could be a constituent contributing to the aroma of green tea leaves. |
Molecular Weight: | 241.24 |
Molecular Formula: | C11H15NO5 |
Canonical SMILES: | COC1=C(C(=C(C(=C1)C(=O)OC)N)OC)OC |
InChI: | InChI=1S/C11H15NO5/c1-14-7-5-6(11(13)17-4)8(12)10(16-3)9(7)15-2/h5H,12H2,1-4H3 |
InChI Key: | UPVUQELOASQBMY-UHFFFAOYSA-N |
Boiling Point: | 127-140 °C0.1 mmHg (lit.) 382.1 °C at 760 mmHg |
Melting Point: | 44-45 °C (lit.) |
Purity: | 95 % |
Density: | 1.196 g/cm3 |
Appearance: | Solid |
MDL: | MFCD00008426 |
LogP: | 1.66240 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2008069611-A1 | N-phenylamide derivative, process for the preparation thereof, and composition for preventing or treating ischemic diseases comprising same | 20061208 |
CA-2592455-A1 | Substituted 2-amino-quinazolin-4-cn compounds for use in the treatment of cns disorders, pain, stroke, addiction and epilepsy, their preaparation and use as intermediates | 20050107 |
CN-101142195-A | Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of C N S disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates | 20050107 |
EP-1841746-A1 | Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of cns disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates | 20050107 |
JP-2008526803-A | Substituted 2-amino-quinazoline 4-CN compounds for use in the treatment of CNS disorders, pain, seizures, addiction and epilepsy, their preparation, and their use as intermediate products | 20050107 |
Complexity: | 260 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 241.09502258 |
Formal Charge: | 0 |
Heavy Atom Count: | 17 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 241.09502258 |
Rotatable Bond Count: | 5 |
Topological Polar Surface Area: | 80 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.6 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
-
[37793-53-6]
N10-(Trifluoroacetyl)pteroic acid
-
[4294-16-0]
N6-Benzyl Adenosine
-
[110782-31-5]
N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-O-methyladenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
-
[14245-62-6]
Isopropyl ethanesulfonate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[1118-71-4]
2,2,6,6-Tetramethyl-3,5-heptanedione
INDUSTRY LEADERS TRUST OUR PRODUCTS